In Vitro Activity of HSR-903, a New Oral Quinolone, against Bacteria Causing Respiratory Infections
The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptoc...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1999
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89361/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390240/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1767 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|